Noticias

20 de septiembre de 2018

Recent research provides a potential new therapy to treat myelodysplastic syndromes and chronic myelomonocytic leukemia

Recent research, led by Ruth Risueño, lead researcher at the Josep Carreras Leukaemia Research Institute, published in the prestigious international journal Scientific Reports, has found a potential new therapy for patients affected by two kinds of blood cancer, myelodysplastic syndromes and chronic myelomonocytic leukaemia, two diseases for which, at present, treatment is insufficiently successful and can have serious side effects.

20180913_ABM-RMR